Please enable JavaScript
Powered by Benchmark MaSS English, Author at Matribhumi Samachar English - Page 1203 of 2835
Friday, March 06 2026 | 07:05:32 PM
Home / MaSS English (page 1203)

MaSS English

BioHarvest Sciences to Present at Canaccord Genuity 45th Annual Growth Conference on August 12-14, 2025

Rehovot, Israel–(Newsfile Corp. – July 23, 2025) – BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) (“BioHarvest” or the “Company”), a company pioneering its patented Botanical Synthesis technology platform, today announced that management has been invited to present at the Canaccord Genuity 45th Annual Growth Conference taking place on August 12-14, …

Read More »

Gatekeeper Announces Closing of its $11.5 Million Bought Deal Private Placement, Including Full Exercise of Underwriters’ Option

Abbotsford, British Columbia–(Newsfile Corp. – July 23, 2025) – Gatekeeper Systems Inc. (TSXV: GSI) (OTC Pink: GKPRF) (“Gatekeeper” or the “Company“), a video and data solutions provider for public transportation and smart cities, is pleased to announce the closing of its previously announced brokered private placement. Canaccord Genuity Corp. acted as lead …

Read More »

24/7 Market News: VENU Closing Its RegA Preferred Stock Offering, as CEO Roth Invests $5 Million in Company

Move Eliminates Ceiling and follows ~$200M Non-Dilutive Commitment from Texas Capital Securities Denver, Colorado–(Newsfile Corp. – July 23, 2025) – 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, reports that Venu Holding Corporation (NYSE American: VENU) (“Venu”), an upscale live …

Read More »

Hemostemix Closes Sale of 23rd ACP-01 Therapy Convertible Debenture

Calgary, Alberta–(Newsfile Corp. – July 23, 2025) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or “HEM”), an autologous angiogenic stem cell therapy company that has safely treated 498 patients for various forms of cardiovascular disease, including peripheral arterial disease, chronic limb threatening ischemia, non ischemic dilated cardiomyopathy, …

Read More »

Assay Results from Glenstar’s Wildhorse Project in Nevada Report Anomolous Copper, Silver, Bismuth, and Tungsten

Vancouver, British Columbia–(Newsfile Corp. – July 23, 2025) – Glenstar Minerals Inc. (CSE: GSTR) (OTCQB: GSTRF) (FSE: VO2) (“Glenstar” or the “Company“) is pleased to announce that it has received assay results from rock grab samples that were collected during the phase 1 exploration program conducted at the Company’s Wildhorse …

Read More »

HYLQ Announces Private Placement

Toronto, Ontario–(Newsfile Corp. – July 23, 2025) – HYLQ Strategy Corp. (CSE: HYLQ) (formerly, Tony G Co-Investment Holdings Ltd.) (the “Company” or “HYLQ Strategy“) is pleased to announce a non-brokered private placement financing for gross proceeds of up to $8,000,000 through the issuance of up to 5,333,333 units (the “Units“) …

Read More »